Funding for this research was provided by:
National Heart, Lung, and Blood Institute (5K08HL143183)
Cystic Fibrosis Foundation (YONKER18Q0)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (1R01HD100022-01)
Received: 13 July 2020
Accepted: 30 August 2020
First Online: 11 September 2020
Ethics approval and consent to participate
: The study received ethics approval from the Partners/Massachusetts General Hospital Institutional Review Board (IRB#2020P000955) and the Partners/Massachusetts General Hospital Institutional Biosafety Committee (IBC#2020B000061). Verbal consent to participate was obtained from the participants or from parents/guardians (for children under 18 years of age). Verbal assent was obtained, when possible, from children ages 7–18 years of age. All participants signed an IRB-approved informed consent prior to participating.
: Not applicable.
: The authors declare no competing interest.